0
Signin
countryflagUS

18889881171

AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

Shanghai Pharmaceuticals Holding Co. Ltd

Healthcare US SHPMF

1.495USD
-(-%)

Last update at 2024-05-15T13:30:00Z

Day Range

1.501.50
LowHigh

52 Week Range

1.212.08
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 8808.35M 8143.81M 7175.48M 6262.47M 5343.38M
Minority interest -1374.86277M -1181.10218M 9386.05M 7726.87M 7419.70M
Net income 5617.15M 5093.47M 4496.22M 4080.99M 3881.06M
Selling general administrative 1196.67M 1409.46M 1320.49M 1381.49M 1184.15M
Selling and marketing expenses 14278.97M 13318.03M 12864.84M 12855.72M 11058.10M
Gross profit 30486.38M 28543.11M 27435.19M 26814.13M 22562.93M
Reconciled depreciation 2222.44M 1067.26M 2130.30M 1877.75M 1162.83M
Ebit 9783.15M 9821.73M 9447.79M 8927.61M 7618.08M
Ebitda 12005.59M 11961.53M 11585.59M 10812.59M 8787.54M
Depreciation and amortization 2222.44M 2139.80M 2137.79M 1884.98M 1169.46M
Non operating income net other - - - - -
Operating income 9014.65M 8205.49M 7184.39M 6213.95M 5208.33M
Other operating expenses 223200.30M 207897.32M 183771.37M 178636.17M 152847.73M
Interest expense 1689.28M 1518.23M 1411.89M 1405.21M 1204.43M
Tax provision 1816.34M 1869.25M 1570.22M 1431.72M 887.12M
Interest income 438.30M 338.18M 288.33M 234.02M 197.40M
Net interest income -1334.70361M -1255.46497M -1198.15698M -1242.63670M -1106.24340M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1816.34M 1869.25M 1570.22M 1431.72M 887.12M
Total revenue 231981.30M 215824.26M 191909.16M 186565.80M 159084.40M
Total operating expenses 21705.38M 20616.17M 19297.41M 18884.50M 16326.27M
Cost of revenue 201494.92M 187281.15M 164473.96M 159751.67M 136521.47M
Total other income expense net -206.29711M -61.67141M -8.90558M 48.52M 135.05M
Discontinued operations - - - - -
Net income from continuing ops 6992.01M 6274.57M 5605.26M 4830.74M 4456.26M
Net income applicable to common shares - 5093.47M 4496.22M 4080.99M 3881.06M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 198134.90M 163435.51M 149185.66M 137026.40M 126879.33M
Intangible assets 6586.75M 6308.66M 5419.08M 4141.97M 4283.17M
Earning assets - - - - -
Other current assets 1403.66M 1114.20M 1256.73M 1116.98M 1234.48M
Total liab 120132.45M 104369.30M 94444.93M 87640.47M 80446.06M
Total stockholder equity 67063.01M 49359.48M 45354.68M 41659.05M 39013.57M
Deferred long term liab 342.61M 688.35M 639.15M 606.39M 568.95M
Other current liab 28125.50M 26732.29M 21233.60M 13407.89M 11523.13M
Common stock 3697.55M 2842.09M 2842.09M 2842.09M 2842.09M
Capital stock 3697.55M 2842.09M 2842.09M 2842.09M 2842.09M
Retained earnings 32479.87M 28598.60M 25054.35M 21970.91M 19330.64M
Other liab - 3952.95M 3626.84M 2742.93M 2097.86M
Good will 11335.93M 11238.97M 11342.27M 10789.92M 11345.29M
Other assets - 3023.85M 2796.15M 5654.35M 2885.76M
Cash 27401.40M 22390.39M 22296.23M 18152.82M 18694.67M
Cash and equivalents - - - - -
Total current liabilities 110691.05M 91824.32M 88132.99M 74607.64M 68709.77M
Current deferred revenue 21740.56M 17499.91M 16214.98M 12219.29M 8824.75M
Net debt 11160.04M 9298.26M 9496.09M 16464.33M 12964.30M
Short term debt 31000.02M 23096.62M 29107.22M 24327.29M 22038.68M
Short long term debt 27750.59M 22514.57M 20139.19M 23138.69M 19340.30M
Short long term debt total 38561.43M 31688.64M 31792.32M 34617.15M 31658.97M
Other stockholder equity 30885.59M 17918.79M 17458.24M 16846.06M 16840.84M
Property plant equipment - 15793.25M 14626.39M 13127.81M 10604.38M
Total current assets 149512.87M 116494.43M 107562.93M 98091.58M 93277.88M
Long term investments - - - 5432.36M 4648.57M
Net tangible assets - 32071.08M 28817.16M 26938.76M 23550.82M
Short term investments 9613.55M - - - -
Net receivables 76634.04M 65885.81M 59921.71M 53944.43M 48324.73M
Long term debt 6259.80M 7157.75M 1184.08M 9134.22M 9620.30M
Inventory 34460.22M 27104.04M 24088.26M 24877.36M 25024.01M
Accounts payable 51565.53M 41995.41M 37792.17M 36872.46M 35147.97M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 11115.70M 12635.22M 9281.45M 10062.76M 6740.51M
Deferred long term asset charges - - - - -
Non current assets total 48622.03M 46941.08M 41622.73M 38934.81M 33601.45M
Capital lease obligations 1301.61M 1434.27M 1501.02M 1155.64M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -12473.12418M -86.67540M -808.24526M -2522.17630M -644.19241M
Change to liabilities 12513.11M 5957.81M 1125.85M 2449.50M 1314.40M
Total cashflows from investing activities - -6015.57589M -1705.67641M -4584.27754M -7692.73998M
Net borrowings - 3243.00M 865.24M 930.67M 7605.92M
Total cash from financing activities 12138.59M 1565.63M -1261.22982M -2325.79853M 7526.32M
Change to operating activities - - 648.79M 648.79M 648.79M
Net income 6992.01M 6274.57M 5605.26M 4830.74M 4456.26M
Change in cash 4396.39M 561.06M 3860.19M -889.29681M 3036.14M
Begin period cash flow 20137.50M 19576.44M 15716.26M 16605.55M 13569.41M
End period cash flow 24533.89M 20137.50M 19576.44M 15716.26M 16605.55M
Total cash from operating activities 4743.36M 5061.33M 6844.72M 6022.39M 3135.11M
Issuance of capital stock - - - - 2624.75M
Depreciation 2222.44M 2139.80M 2137.79M 1884.98M 1169.46M
Other cashflows from investing activities - 606.31M 1562.35M 1242.81M 453.20M
Dividends paid -3093.89167M -2675.91993M -2418.39455M -2584.16351M 2357.76M
Change to inventory -7111.70459M -3200.96080M 932.60M 63.14M -2842.90218M
Change to account receivables -10081.41712M -6155.51004M -4072.16846M -5083.63293M -2183.15929M
Sale purchase of stock - - - - 60659.64M
Other cashflows from financing activities 75041.15M 56456.11M 48732.64M 38598.67M 60465.92M
Change to netincome - 1039.82M 2063.77M 2492.55M 1663.51M
Capital expenditures 2684.86M 4118.77M 3009.97M 2753.13M 1943.04M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -4680.01156M -3398.65692M -2013.71738M -2570.98956M -3711.66207M
Stock based compensation - - - - -
Other non cash items 208.92M 45.61M 1115.38M 1877.66M 1221.05M
Free cash flow 2058.50M 942.55M 3834.75M 3269.26M 1192.07M

Fundamentals

  • Previous Close 1.50
  • Market Cap7746.65M
  • Volume0
  • P/E Ratio7.71
  • Dividend Yield6.46%
  • EBITDA10182.92M
  • Revenue TTM254877.70M
  • Revenue Per Share TTM67.83
  • Gross Profit TTM 28407.88M
  • Diluted EPS TTM0.17

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SHPMF
Shanghai Pharmaceuticals Holding Co. Ltd		 - -% 1.50 7.71 5.45 0.03 0.57 0.03 0.88
MCK
McKesson Corporation		 3.31 0.60% 554.87 17.95 14.53 0.20 5.04 0.22 12.17
COR
Cencora Inc.		 -0.461 0.21% 221.35 23.39 - - -
CAH
Cardinal Health Inc		 1.29 1.33% 98.41 166.11 14.71 0.12 16.07 0.12 19.78
HSIC
Henry Schein Inc		 -0.06 0.08% 74.68 21.82 14.33 0.76 2.63 0.92 12.98

Reports Covered

Stock Research & News

View All

Profile

Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

Shanghai Pharmaceuticals Holding Co. Ltd

Shanghai Pharmaceutical Building, Shanghai, China, 200020

Key Executives

Name Title Year Born
Mr. Man Cho Pres & Exec. Director 1961
Mr. Bo Shen CFO, VP, Head of the Accounting Department & Exec. Director 1973
Mr. Yongzhong Li VP & Exec. Director 1970
Dr. Shunjiang Yu Chief Medical Officer NA
Ms. Shui Bing Leung A.C.S. Joint Company Sec. 1977
Mr. Tao Zhong VP, Board Sec. & Joint Company Sec. 1972
Jinqi Yu Gen. Mang. NA
Ying Ke Director & Gen. Mang. of R&D Management Center NA
Linqiong Dong Securities Affairs Representative NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).